About EANM 2026
The 39th EANM Annual Congress will be held from October 17–21, 2026, at the Austria Center Vienna (ACV) in Vienna, Austria. As the world's leading meeting for nuclear medicine and molecular imaging, it is expected to attract over 9,000 participants and features more than 150 sessions covering advanced topics such as Personalised Theranostics, radiopharmaceuticals, and AI integration.
The scientific programme of the congress is developed under a renewed governance model. As Chair of the EANM Scientific Events Council Chair, I oversee the programme together with seven distinguished experts. This newly created EANM Council, launched in January 2026, reflects our commitment to diversity of expertise, openness of perspectives, and scientific excellence. The result is a programme that is both rigorous and forward-looking, shaped by collective intelligence rather than individual vision.
EANM'26 will highlight outstanding research across the full spectrum of nuclear medicine, from breakthrough developments in theranostics and radiopharmaceutical sciences to innovative imaging technologies, quantitative approaches, and clinical translation. As always, the strength of the congress lies in the quality of the science you bring — your research, your curiosity, and your willingness to challenge established paradigms.
The congress aims to stimulate interaction across disciplines, professional backgrounds, and generations. Engaging and empowering younger colleagues remains a strategic priority, as they will drive the next transformations of our specialty. Creating spaces for dialogue, mentorship, and exchange is essential to ensure that progress remains sustainable and inclusive; and we will make sure to embrace this aspect again during our congress.